These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 30203113
1. Long-term effects of tacrolimus for maintenance therapy of lupus nephritis: a 5-year retrospective study at a single center. Karasawa K, Uchida K, Kodama M, Moriyama T, Nitta K. Rheumatol Int; 2018 Dec; 38(12):2271-2277. PubMed ID: 30203113 [Abstract] [Full Text] [Related]
2. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial. Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V. Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558 [Abstract] [Full Text] [Related]
3. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice. Tanaka H, Watanabe S, Aizawa-Yashiro T, Oki E, Kumagai N, Tsuruga K, Ito E. Nephron Clin Pract; 2012 Apr; 121(3-4):c165-73. PubMed ID: 23327881 [Abstract] [Full Text] [Related]
4. Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study. Fei Y, Wu Q, Zhang W, Chen H, Hou Y, Xu D, Li M, Zhang X, Zhao Y, Zeng X, Zhang F. Clin Exp Rheumatol; 2013 Apr; 31(1):62-8. PubMed ID: 22935463 [Abstract] [Full Text] [Related]
5. Long-term data on tacrolimus treatment in lupus nephritis. Yap DY, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM. Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908 [Abstract] [Full Text] [Related]
6. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis. Choi CB, Won S, Bae SC. Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881 [Abstract] [Full Text] [Related]
7. Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center. Asamiya Y, Uchida K, Otsubo S, Takei T, Nitta K. Nephron Clin Pract; 2009 May; 113(4):c330-6. PubMed ID: 19729969 [Abstract] [Full Text] [Related]
8. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan. Sakai R, Kurasawa T, Nishi E, Kondo T, Okada Y, Shibata A, Nishimura K, Chino K, Okuyama A, Takei H, Nagasawa H, Amano K. Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654 [Abstract] [Full Text] [Related]
9. Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study. Miyasaka N, Kawai S, Hashimoto H. Mod Rheumatol; 2009 Feb; 19(6):606-15. PubMed ID: 19688181 [Abstract] [Full Text] [Related]
10. Moderator's view: The use of calcineurin inhibitors in the treatment of lupus nephritis. Kronbichler A, Neumann I, Mayer G. Nephrol Dial Transplant; 2016 Oct; 31(10):1572-6. PubMed ID: 27591329 [Abstract] [Full Text] [Related]
11. Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis. Takahashi S, Hiromura K, Sakurai N, Matsumoto T, Ikeuchi H, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y. Mod Rheumatol; 2011 Jun; 21(3):282-9. PubMed ID: 21188448 [Abstract] [Full Text] [Related]
12. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up. Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL. Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339 [Abstract] [Full Text] [Related]
13. Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis. Nomura A, Shimizu H, Kishimoto M, Suyama Y, Rokutanda R, Ohara Y, Yamaguchi K, Okada M. Lupus; 2012 Nov; 21(13):1444-9. PubMed ID: 22917589 [Abstract] [Full Text] [Related]
14. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria. Uchino A, Tsukamoto H, Nakashima H, Yoshizawa S, Furugo I, Mitoma H, Oryoji K, Shimoda T, Niiro H, Tada Y, Yano T, Nonaka T, Oishi R, Akashi K, Horiuchi T. Clin Exp Rheumatol; 2010 Nov; 28(1):6-12. PubMed ID: 20346231 [Abstract] [Full Text] [Related]
15. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study. Mok CC, Tong KH, To CH, Siu YP, Au TC. Kidney Int; 2005 Aug; 68(2):813-7. PubMed ID: 16014060 [Abstract] [Full Text] [Related]
16. Post-marketing surveillance study of the long-term use of mizoribine for the treatment of lupus nephritis: 2-Year results. Takeuchi T, Okada K, Yoshida H, Yagi N. Mod Rheumatol; 2018 Jan; 28(1):85-94. PubMed ID: 28722500 [Abstract] [Full Text] [Related]
17. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose. Tanaka H, Oki E, Tsuruga K, Yashiro T, Hanada I, Ito E. Clin Nephrol; 2009 Dec; 72(6):430-6. PubMed ID: 19954719 [Abstract] [Full Text] [Related]
18. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study. Mok CC, To CH, Yu KL, Ho LY. Lupus; 2013 Oct; 22(11):1135-41. PubMed ID: 23995863 [Abstract] [Full Text] [Related]
19. Mizoribine for the treatment of lupus nephritis in children and adolescents. Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S. Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899 [Abstract] [Full Text] [Related]
20. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis. Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H. Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642 [Abstract] [Full Text] [Related] Page: [Next] [New Search]